diallyl trisulfide has been researched along with Glioma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hwang, JS; Kwon, KH; Lee, DH; Lee, YY | 1 |
Liu, N; Niu, L; Qin, J; Tao, Q; Wang, C; Wu, C; Xu, R; Zhang, P | 1 |
2 other study(ies) available for diallyl trisulfide and Glioma
Article | Year |
---|---|
DATS sensitizes glioma cells to TRAIL-mediated apoptosis by up-regulation of death receptor 5 via ROS.
Topics: Allyl Compounds; Apoptosis; Cell Line, Tumor; Glioma; Humans; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; Sulfides; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Up-Regulation | 2017 |
Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of glioma cells by inactivating Wnt/β-catenin signaling.
Topics: Allyl Compounds; Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Intracellular Signaling Peptides and Proteins; Low Density Lipoprotein Receptor-Related Protein-6; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Sulfides; Transcription Factors; Wnt Proteins; Wnt Signaling Pathway | 2017 |